OR4K7P

Across TCGA pan-cancer cohorts, OR4K7P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR4K7P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where OR4K7P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR4K7P is over-expressed in tumor.

BRCA and PRAD are the cancer types where OR4K7P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR4K7P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.184	.002	6	view →
PRAD	All	All	+0.017	.031	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

OR4K7P–BRCA

Open the BRCA breakdown →